Reuters logo
2 years ago
BRIEF-FDA completes Biofrontera's Ameluz NDA mid-cycle review
January 26, 2016 / 9:58 AM / 2 years ago

BRIEF-FDA completes Biofrontera's Ameluz NDA mid-cycle review

Jan 26 (Reuters) - Biofrontera AG :

* FDA completes Biofrontera's Ameluz NDA mid-cycle review

* Review resulted in no additional requests for material nor were any additional review issues highlighted Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below